Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.
Chen X, Cherian S.
Clin Lab Med. 2017 Dec;37(4):753-769. doi: 10.1016/j.cll.2017.07.003. Epub 2017 Aug 31.
Acute promyelocytic leukemia current treatment algorithms.
Yilmaz M, Kantarjian H, Ravandi F.
Blood Cancer J. 2021 Jun 30;11(6):123. doi: 10.1038/s41408-021-00514-3.
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.
Gottschlich A, Thomas M, Grünmeier R, Lesch S, Rohrbacher L, Igl V, Briukhovetska D, Benmebarek MR, Vick B, Dede S, Müller K, Xu T, Dhoqina D, Märkl F, Robinson S, Sendelhofert A, Schulz H, Umut Ö, Kavaka V, Tsiverioti CA, Carlini E, Nandi S, Strzalkowski T, Lorenzini T, Stock S, Müller PJ, Dörr J, Seifert M, Cadilha BL, Brabenec R, Röder N, Rataj F, Nüesch M, Modemann F, Wellbrock J, Fiedler W, Kellner C, Beltrán E, Herold T, Paquet D, Jeremias I, von Baumgarten L, Endres S, Subklewe M, Marr C, Kobold S.
Nat Biotechnol. 2023 Nov;41(11):1618-1632. doi: 10.1038/s41587-023-01684-0. Epub 2023 Mar 13.
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Jongen-Lavrencic M, Grob T, Hanekamp D, Kavelaars FG, Al Hinai A, Zeilemaker A, Erpelinck-Verschueren CAJ, Gradowska PL, Meijer R, Cloos J, Biemond BJ, Graux C, van Marwijk Kooy M, Manz MG, Pabst T, Passweg JR, Havelange V, Ossenkoppele GJ, Sanders MA, Schuurhuis GJ, Löwenberg B, Valk PJM.
N Engl J Med. 2018 Mar 29;378(13):1189-1199. doi: 10.1056/NEJMoa1716863.
Genomic Landscape of Mixed-Phenotype Acute Leukemia.
Hennawi M, Pakasticali N, Tashkandi H, Hussaini M.
Int J Mol Sci. 2022 Sep 24;23(19):11259. doi: 10.3390/ijms231911259.
Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
Gorczyca W, Sun ZY, Cronin W, Li X, Mau S, Tugulea S.
Methods Cell Biol. 2011;103:221-66. doi: 10.1016/B978-0-12-385493-3.00010-3.
[Acute myeloid Leukemia].
Braess J.
Dtsch Med Wochenschr. 2016 Nov;141(24):1748-1751. doi: 10.1055/s-0042-112505. Epub 2016 Nov 11.
Multiparameter flow cytometry in the diagnosis and management of acute leukemia.
Peters JM, Ansari MQ.
Arch Pathol Lab Med. 2011 Jan;135(1):44-54. doi: 10.5858/2010-0387-RAR.1.
Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion.
Klaihmon P, Samart P, Rojanasakul Y, Issaragrisil S, Luanpitpong S.
Exp Hematol Oncol. 2024 Jul 11;13(1):67. doi: 10.1186/s40164-024-00534-2.
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cavé H, Pane F, Aerts JL, De Micheli D, Thirion X, Pradel V, González M, Viehmann S, Malec M, Saglio G, van Dongen JJ.
Leukemia. 2003 Dec;17(12):2318-57. doi: 10.1038/sj.leu.2403135.
